Association of IRF5 polymorphism with MPO-ANCA-positive vasculitis in a Japanese population

Genes and Immunity

Volumn 14, Issue 8, 2013, Pages 527-529

  Kawasaki, A ^a   Inoue, N ^a   Ajimi, C ^a   Sada, K E ^b   Kobayashi, S ^c   Yamada, H ^d   Furukawa, H ^e   Sumida, T ^a   Tohma, S ^e   Miyasaka, N ^f   Matsuo, S ^g   Ozaki, S ^d   Hashimoto, H ^h   Makino, H ^b   Harigai, M ^f   Tsuchiya, N ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Juntendo University Hospital   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ANCA associated vasculitis; IRF5; myeloperoxidase; polymorphism

Indexed keywords

MYELOPEROXIDASE; STAT4 PROTEIN;

AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; INTERFERON REGULATORY FACTOR 5 GENE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERFERON REGULATORY FACTORS; JAPAN; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; STAT4 TRANSCRIPTION FACTOR;

EID: 84889643944     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.45     Document Type: Article

References (26)

1. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology 2011; 50: 1916-1920.
2. Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol 2009; 13: 633-650.
3. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53: 743-753.
4. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367: 214-223.
5. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
6. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75: 504-507.
7. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005; 52: 4039-4043.
8. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol 2003; 30: 1534-1540.
9. Tsuchiya N, Kobayashi S, Hashimoto H, Ozaki S, Tokunaga K. Association of HLADRB1* 0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun 2006; 7: 81-84.
10. Shimane K, Kochi Y, Suzuki A, Okada Y, Ishii T, Horita T et al. An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes. Rheumatology 2013; 52: 1172-1182.
11. Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T et al. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol 2007; 25: 219-224.
12. Kyogoku C, Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007; 8: 445-455.
13. Ito I, Kawaguchi Y, Kawasaki A, Hasegawa M, Ohashi J, Hikami K et al. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum 2009; 60: 1845-1850.
14. Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D et al. Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res Ther 2008; 10: R113.
15. Tsuchiya N, Kawasaki A, Hasegawa M, Fujimoto M, Takehara K, Kawaguchi Y et al. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann Rheum Dis 2009; 68: 1375-1376.
16. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004; 202: 139-156.
17. Knight A, Sandin S, Askling J. Increased risk of autoimmune disease in families with Wegener's granulomatosis. J Rheumatol 2010; 37: 2553-2558.
18. Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA et al. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008; 58: 1465-1474.
19. Alcorta DA, Barnes DA, Dooley MA, Sullivan P, Jonas B, Liu Y et al. Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int 2007; 72: 853-864.
20. Lyons PA, McKinney EF, Rayner TF, Hatton A, Woffendin HB, Koukoulaki M et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann Rheum Dis 2010; 69: 1208-1213.
21. Uno K, Muso E, Ito-Ihara T, Omatsu Y, Inaba K, Yagi K et al. Dysfunction of IFN system causes susceptibility to infection in patients with MPO-ANCA-associated vasculitis. The Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012 2012 p106 (abstract PW3-3).
22. Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 2004; 279: 45194-45207.
23. Wieczorek S, Holle JU, Mü ller S, Fricke H, Gross WL, Epplen JT. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. J Mol Med 2010; 88: 413-421.
24. Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 2008; 58: 826-834.
25. Chung SA, Xie G, Roshandel D, Sherva R, Edberg JC, Kravitz M et al. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. Arthritis Rheum 2012; 64: 3463-3471.
26. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W et al. Development and validation of a consensus methodology for the classification of the ANCAassociated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66: 222-227.